Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
Anticancer Res
    January 2018
  1. SVOBODOVA S, Kucera R, Fiala O, Marie K, et al
    CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer.
    Anticancer Res. 2018;38:465-469.
    >> Share

  2. KASHIWAGI S, Asano Y, Goto W, Takada K, et al
    Mesenchymal-epithelial Transition and Tumor Vascular Remodeling in Eribulin Chemotherapy for Breast Cancer.
    Anticancer Res. 2018;38:401-410.
    >> Share

  3. TAKASHIMA T, Kawajiri H, Nishimori T, Tei S, et al
    Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast Cancer.
    Anticancer Res. 2018;38:379-383.
    >> Share

  4. CHAMARAUX-TRAN TN, Mathelin C, Aprahamian M, Joshi GP, et al
    Antitumor Effects of Lidocaine on Human Breast Cancer Cells: An In Vitro and In Vivo Experimental Trial.
    Anticancer Res. 2018;38:95-105.
    >> Share

  5. JARDEL P, Vignot S, Cutuli B, Creisson A, et al
    Should Adjuvant Radiation Therapy Be Systematically Proposed for Male Breast Cancer? A Systematic Review.
    Anticancer Res. 2018;38:23-31.
    >> Share

    December 2017
  6. PESSINA F, Navarria P, Cozzi L, Franceschini D, et al
    Outcome Evaluation of HER2 Breast Cancer Patients with Limited Brain Metastasis.
    Anticancer Res. 2017;37:7057-7062.
    >> Share

  7. YAMANOUCHI K, Kuba S, Sakimura C, Morita M, et al
    The Relationship Between Peripheral Neuropathy Induced by Docetaxel and Systemic Inflammation-based Parameters in Patients with Breast Cancer.
    Anticancer Res. 2017;37:6947-6951.
    >> Share

  8. MOKBEL K, Wazir U, El Hage Chehade H, Manson A, et al
    A Comparison of the Performance of EndoPredict Clinical and NHS PREDICT in 120 Patients Treated for ER-positive Breast Cancer.
    Anticancer Res. 2017;37:6863-6869.
    >> Share

  9. NIMEUS E, Folkesson E, Nodin B, Hartman L, et al
    Androgen Receptor in Stage I-II Primary Breast Cancer -Prognostic Value and Distribution in Subgroups.
    Anticancer Res. 2017;37:6845-6853.
    >> Share

  10. AULA H, Skytta T, Tuohinen S, Luukkaala T, et al
    Adjuvant Breast Cancer Treatments Induce Changes in Homoarginine Level - A Prospective Observational Study.
    Anticancer Res. 2017;37:6815-6824.
    >> Share

  11. PEREIRA MC, Mohammed R, VAN Otterlo WAL, DE Koning CB, et al
    Evaluation of the Effects of Aminonaphthoquinone Derivatives in Combination with Curcumin Against ER-positive Breast Cancer and Related Tumours.
    Anticancer Res. 2017;37:6749-6759.
    >> Share

  12. STOPE MB, Weiss M, Koensgen D, Popp SL, et al
    Y-box Binding Protein-1 Enhances Oncogenic Transforming Growth Factor beta Signaling in Breast Cancer Cells via Triggering Phospho-Activation of Smad2.
    Anticancer Res. 2017;37:6745-6748.
    >> Share

  13. MATSUI C, Takatani-Nakase T, Maeda S, Nakase I, et al
    Potential Roles of GLUT12 for Glucose Sensing and Cellular Migration in MCF-7 Human Breast Cancer Cells Under High Glucose Conditions.
    Anticancer Res. 2017;37:6715-6722.
    >> Share

  14. KAR A, Liu B, Gutierrez-Hartmann A
    ESE-1 Knockdown Attenuates Growth in Trastuzumab-resistant HER2(+) Breast Cancer Cells.
    Anticancer Res. 2017;37:6583-6591.
    >> Share

  15. SPARTALIS E, Tsilimigras DI, Charalampoudis P, Karachaliou GS, et al
    The "Yin and Yang" of Platelet-rich Plasma in Breast Reconstruction After Mastectomy or Lumpectomy for Breast Cancer.
    Anticancer Res. 2017;37:6557-6562.
    >> Share

  16. MIRKA H, Tupy R, Narsanska A, Hes O, et al
    Pre-surgical Multiparametric Assessment of Breast Lesions Using 3-Tesla Magnetic Resonance.
    Anticancer Res. 2017;37:6965-6970.
    >> Share

  17. SAPINHO G, Alho I, Bicho M, Coelho C, et al
    Total Knockdown of LMW-PTP in MDA-MB-231 Cells Reduces Osteoclastogenesis.
    Anticancer Res. 2017;37:6671-6677.
    >> Share

  18. MANOUCHEHRI JM, Kalafatis M
    Sensitization of rhTRAIL-resistant Triple-negative Breast Carcinoma Through Silibinin Co-Treatment.
    Anticancer Res. 2017;37:6593-6599.
    >> Share

  19. CHRISTOPOULOS PF, Vlachogiannis NI, Vogkou CT, Koutsilieris M, et al
    The Role of the Androgen Receptor Signaling in Breast Malignancies.
    Anticancer Res. 2017;37:6533-6540.
    >> Share

    November 2017
  20. MATSUI A, Tatibana A, Suzuki N, Hirata M, et al
    Evaluation of Efficacy and Safety of Upfront Weekly Nanoparticle Albumin-bound Paclitaxel for HER2-negative Breast Cancer.
    Anticancer Res. 2017;37:6481-6488.
    >> Share

  21. SHEIKH IA, Jiffri EH, Kamal MA, Ashraf GM, et al
    Lactoperoxidase, an Antimicrobial Milk Protein, as a Potential Activator of Carcinogenic Heterocyclic Amines in Breast Cancer.
    Anticancer Res. 2017;37:6415-6420.
    >> Share

  22. SHEIKH IA, Beg MA, Yasir M
    Molecular Interactions of Carcinogenic Aromatic Amines, 4-Aminobiphenyl and 4,4'-Diaminobiphenyl, with Lactoperoxidase - Insight to Breast Cancer.
    Anticancer Res. 2017;37:6245-6249.
    >> Share

  23. JEON D, Kim H, Nam K, Oh S, et al
    Cytotoxic Effect of Nano-SiO2 in Human Breast Cancer Cells via Modulation of EGFR Signaling Cascades.
    Anticancer Res. 2017;37:6189-6197.
    >> Share

  24. WAKIMOTO R, Ono M, Takeshima M, Higuchi T, et al
    Differential Anticancer Activity of Pterostilbene Against Three Subtypes of Human Breast Cancer Cells.
    Anticancer Res. 2017;37:6153-6159.
    >> Share

  25. DU J, Sun Y, Lu YY, Lau E, et al
    Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis.
    Anticancer Res. 2017;37:6141-6151.
    >> Share

    October 2017
  26. SHOJI F, Yamashita N, Inoue Y, Kozuma Y, et al
    Surgical Resection and Outcome of Synchronous and Metachronous Primary Lung Cancer in Breast Cancer Patients.
    Anticancer Res. 2017;37:5871-5876.
    >> Share

  27. KARMAKAR MK, Samy W, Lee A, Li JW, et al
    Survival Analysis of Patients with Breast Cancer Undergoing a Modified Radical Mastectomy With or Without a Thoracic Paravertebral Block: a 5-Year Follow-up of a Randomized Controlled Trial.
    Anticancer Res. 2017;37:5813-5820.
    >> Share

  28. HE K, Wang X, Guan X, Yu Q, et al
    Vinorelbine Plus Gemcitabine or Cisplatin as First-line Treatment of HER2-negative Advanced Breast Cancer.
    Anticancer Res. 2017;37:5647-5653.
    >> Share

  29. KASHIWAGI S, Asano Y, Goto W, Takada K, et al
    Using TILs to Predict Therapeutic Effect of Chemotherapy (Pertuzumab, Trastuzumab, Docetaxel) on HER2-positive Breast Cancer.
    Anticancer Res. 2017;37:5623-5630.
    >> Share

  30. CHU QD, Zhou M, Medeiros KL, Peddi P, et al
    Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (>/=70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
    Anticancer Res. 2017;37:5585-5594.
    >> Share

  31. PHAM DH, Kim JS, Kim SK, Shin DJ, et al
    Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells In Vitro.
    Anticancer Res. 2017;37:5507-5513.
    >> Share

  32. BOBIN-DUBIGEON C, Chauvin A, Brillaud-Meflah V, Boiffard F, et al
    Liver X Receptor (LXR)-regulated Genes of Cholesterol Trafficking and Breast Cancer Severity.
    Anticancer Res. 2017;37:5495-5498.
    >> Share

  33. CALIS IU, Cosan DT, Mutlu F
    Effects of S1P1 and S1P3 in ER+ and ER- Breast Cancer Cells.
    Anticancer Res. 2017;37:5469-5475.
    >> Share

  34. GIGLI S, Amabile MI, DI Pastena F, DE Luca A, et al
    Lipofilling Outcomes Mimicking Breast Cancer Recurrence: Case Report and Update of the Literature.
    Anticancer Res. 2017;37:5395-5398.
    >> Share

  35. HARUNA F, Lipsett A, Marignol L
    Topical Management of Acute Radiation Dermatitis in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Anticancer Res. 2017;37:5343-5353.
    >> Share

  36. GLASSMAN D, Hignett S, Rehman S, Linforth R, et al
    Adjuvant Endocrine Therapy for Hormone-positive Breast Cancer, Focusing on Ovarian Suppression and Extended Treatment: An Update.
    Anticancer Res. 2017;37:5329-5341.
    >> Share

  37. GRZEGRZOLKA J, Wojtyra P, Biala M, Piotrowska A, et al
    Correlation Between Expression of Twist and Podoplanin in Ductal Breast Carcinoma.
    Anticancer Res. 2017;37:5485-5493.
    >> Share

    September 2017
  38. KRAMMER J, Stepniewski K, Kaiser CG, Brade J, et al
    Value of Additional Digital Breast Tomosynthesis for Preoperative Staging of Breast Cancer in Dense Breasts.
    Anticancer Res. 2017;37:5255-5261.
    >> Share

  39. YAMASHITA N, Tokunaga E, Yamamoto H, Shimizu C, et al
    The Local Recurrence of Breast Cancer with Squamous Metaplasia and Obvious Histological Heterogeneity.
    Anticancer Res. 2017;37:5249-5254.
    >> Share

  40. RICCIARDI E, Tomao F, Aletti G, Bazzurini L, et al
    Risk-reducing Salpingo-Oophorectomy in Women at Higher Risk of Ovarian and Breast Cancer: A Single Institution Prospective Series.
    Anticancer Res. 2017;37:5241-5248.
    >> Share

  41. WAKAHARA M, Sakabe T, Kubouchi Y, Hosoya K, et al
    Subcellular Localization of Maspin Correlates with Histone Deacetylase 1 Expression in Human Breast Cancer.
    Anticancer Res. 2017;37:5071-5077.
    >> Share

  42. PAN E, Tung L, Ragab O, Morocco E, et al
    Inflammatory Breast Cancer Outcomes in a Contemporary Series.
    Anticancer Res. 2017;37:5057-5063.
    >> Share

  43. CHOU AK, Hsiao CL, Shih TC, Wang HC, et al
    The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes in Breast Cancer in Taiwan.
    Anticancer Res. 2017;37:4973-4977.
    >> Share

  44. KORASHY HM, Maayah ZH, Al Anazi FE, Alsaad AM, et al
    Sunitinib Inhibits Breast Cancer Cell Proliferation by Inducing Apoptosis, Cell-cycle Arrest and DNA Repair While Inhibiting NF-kappaB Signaling Pathways.
    Anticancer Res. 2017;37:4899-4909.
    >> Share

  45. TIMMER M, Werner JM, Rohn G, Ortmann M, et al
    Discordance and Conversion Rates of Progesterone-, Estrogen-, and HER2/neu-Receptor Status in Primary Breast Cancer and Brain Metastasis Mainly Triggered by Hormone Therapy.
    Anticancer Res. 2017;37:4859-4865.
    >> Share

  46. FANG QI, Wang X, Luo G, Yu M, et al
    Increased CXCL8 Expression Is Negatively Correlated with the Overall Survival of Patients with ER-Negative Breast Cancer.
    Anticancer Res. 2017;37:4845-4852.
    >> Share

  47. KIM D, Radin D, Leonardi D
    Probing the Molecular Mechanisms Governing the Oncolytic Activity of Paeonia suffruticosa on Triple-negative Breast Cancer Cells In Vitro.
    Anticancer Res. 2017;37:4813-4819.
    >> Share

  48. KUBAN-JANKOWSKA A, Sahu KK, Gorska-Ponikowska M, Tuszynski JA, et al
    Inhibitory Activity of Iron Chelators ATA and DFO on MCF-7 Breast Cancer Cells and Phosphatases PTP1B and SHP2.
    Anticancer Res. 2017;37:4799-4806.
    >> Share

  49. ISHITOBI M, Fukui R, Hashimoto Y, Kittaka N, et al
    Safety for Repeat Lumpectomy Without Radiotherapy for Ipsilateral Breast Tumor Recurrence.
    Anticancer Res. 2017;37:5293-5299.
    >> Share

  50. EICHLER C, Abrar S, Puppe J, Arndt M, et al
    Detection of Ductal Carcinoma In Situ by Ultrasound and Mammography: Size-dependent Inaccuracy.
    Anticancer Res. 2017;37:5065-5070.
    >> Share

  51. FUJII T, Yanai K, Tokuda S, Nakazawa Y, et al
    Clinicopathological Features of Ductal Carcinoma In Situ from 18F-FDG-PET Findings.
    Anticancer Res. 2017;37:5053-5056.
    >> Share

  52. UEHARA S, Saito K, Asami H, Ohta Y, et al
    Role of ARHGAP24 in ADP Ribosylation Factor 6 (ARF6)-dependent Pseudopod Formation in Human Breast Carcinoma Cells.
    Anticancer Res. 2017;37:4837-4844.
    >> Share

    August 2017
  53. ZHOU B, Xu L, Ye J, Xin L, et al
    The Prognostic Value of the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging System in HER2-Enriched Subtype Breast Cancer, a Retrospective Analysis.
    Anticancer Res. 2017;37:4615-4621.
    >> Share

  54. LANG Z, Wu Y, Li C, Li X, et al
    Multifocal and Multicentric Breast Carcinoma: A Significantly More Aggressive Tumor than Unifocal Breast Cancer.
    Anticancer Res. 2017;37:4593-4598.
    >> Share

  55. QIN T, Zeng YD, Lu Q, Zhang X, et al
    Nomogram Model of LNR Predicts Survival in Premenopausal Patients with Node-positive Luminal Breast Cancer.
    Anticancer Res. 2017;37:4575-4586.
    >> Share

  56. YE J, Wang W, Xin L, Owen S, et al
    The Clinicopathological Factors Associated with Disease Progression in Luminal A Breast Cancer and Characteristics of Metastasis: A Retrospective Study from A Single Center in China.
    Anticancer Res. 2017;37:4549-4556.
    >> Share

  57. ZENG Y, Li Q, Qin T, Li S, et al
    Impact of a 21-Gene Recurrence Score Test on the Choice of Adjuvant Chemotherapy for Hormone Receptor-positive Early-stage Breast Cancer: A Prospective Study.
    Anticancer Res. 2017;37:4539-4547.
    >> Share

  58. MALIK MFA, Riaz SK, Waqar SH, Haq F, et al
    Role of Plexin B1 in a Breast Cancer Cohort of Pakistani Patients and its Contribution Towards Cancer Metastasis as Indicated by an In Vitro Model.
    Anticancer Res. 2017;37:4483-4488.
    >> Share

  59. LI Z, Peng Z, Gu S, Zheng J, et al
    Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Anticancer Res. 2017;37:4455-4468.
    >> Share

  60. RIAZ SK, Ye L, Sahar NE, Aman D, et al
    Transcriptional Profiling of Sonic Hedgehog in a Prospective Cohort of Breast Cancer in a Pakistani Population.
    Anticancer Res. 2017;37:4449-4454.
    >> Share

  61. WANG L, Qi Y, Xiong Y, Peng Z, et al
    Ezrin-Radixin-Moesin Binding Phosphoprotein 50 (EBP50) Suppresses the Metastasis of Breast Cancer and HeLa Cells by Inhibiting Matrix Metalloproteinase-2 Activity.
    Anticancer Res. 2017;37:4353-4360.
    >> Share

  62. LIANG G, Liu Z, Tan L, Su AN, et al
    HIF1alpha-associated circDENND4C Promotes Proliferation of Breast Cancer Cells in Hypoxic Environment.
    Anticancer Res. 2017;37:4337-4343.
    >> Share

  63. LIU Z, Liang G, Tan L, Su AN, et al
    High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
    Anticancer Res. 2017;37:4329-4335.
    >> Share

  64. UHERCIK M, Sanders AJ, Owen S, Davies EL, et al
    Clinical Significance of PD1 and PDL1 in Human Breast Cancer.
    Anticancer Res. 2017;37:4249-4254.
    >> Share

  65. KLAPKO O, Ghoulam E, Jakate S, Eswaran S, et al
    Anastrozole-induced Autoimmune Hepatitis: A Rare Complication of Breast Cancer Therapy.
    Anticancer Res. 2017;37:4173-4176.
    >> Share

  66. CARBONNELLE D, Luu TH, Chaillou C, Huvelin JM, et al
    LXR Activation Down-regulates Lipid Raft Markers FLOT2 and DHHC5 in MCF-7 Breast Cancer Cells.
    Anticancer Res. 2017;37:4067-4073.
    >> Share

  67. SOBKOWICZ AD, Sanders AJ, Mason MD, Jiang WG, et al
    Potential Implication of Paxillin in Cancer Establishment Within the Bone Environment.
    Anticancer Res. 2017;37:4255-4268.
    >> Share

    July 2017
  68. REMO M, Abraham I, Kankanala V, Chacra W, et al
    Hepatitis B Reactivation in a Patient Receiving Chemotherapy for Breast Cancer: A Case Report.
    Anticancer Res. 2017;37:3791-3793.
    >> Share

  69. MESCHER C, Ding C, Defor T, Konety S, et al
    Left Ventricular Ejection Fraction Screening and Clinical Decision-making in Metastatic HER2-positive Breast Cancer.
    Anticancer Res. 2017;37:3751-3755.
    >> Share

  70. CHIRICO A, D'Aiuto G, Penon A, Mallia L, et al
    Self-Efficacy for Coping with Cancer Enhances the Effect of Reiki Treatments During the Pre-Surgery Phase of Breast Cancer Patients.
    Anticancer Res. 2017;37:3657-3665.
    >> Share

  71. ORFANIDOU T, Xanthopoulos K, Dafou D, Pseftogas A, et al
    Down-regulation of the Tumor Suppressor CYLD Enhances the Transformed Phenotype of Human Breast Cancer Cells.
    Anticancer Res. 2017;37:3493-3503.
    >> Share

  72. ALCANTARA DZ, Soliman IJS, Pobre RF, Naguib RNG, et al
    Effects of Pulsed Electromagnetic Fields on Breast Cancer Cell Line MCF 7 Using Absorption Spectroscopy.
    Anticancer Res. 2017;37:3453-3459.
    >> Share

  73. HU T, Su F, Jiang W, Dart DA, et al
    Overexpression of Activin Receptor-like Kinase 7 in Breast Cancer Cells Is Associated with Decreased Cell Growth and Adhesion.
    Anticancer Res. 2017;37:3441-3451.
    >> Share

  74. KOBAYASHI H, Hamasaki M, Morishita T, Inoue T, et al
    Analysis of Evolving Clinicopathological Features of Metastatic Brain Tumors Over 30 Years of Surgical Management.
    Anticancer Res. 2017;37:3969-3974.
    >> Share

  75. KONDO H, Shimono Y, Mukohyama J, Tanaka Y, et al
    Discordance of MCM7 mRNA and its Intronic MicroRNA Levels Under Hypoxia.
    Anticancer Res. 2017;37:3885-3890.
    >> Share

  76. MADEKIVI V, Bostrom P, Aaltonen R, Vahlberg T, et al
    The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary Dissection.
    Anticancer Res. 2017;37:3757-3762.
    >> Share

  77. MARIAMPILLAI AI, Cruz JPD, Suh J, Sivapiragasam A, et al
    Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries.
    Anticancer Res. 2017;37:3649-3656.
    >> Share

    June 2017
  78. FURRER D, Jacob S, Caron C, Sanschagrin F, et al
    Concordance of HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Using Tissue Microarray in Breast Cancer.
    Anticancer Res. 2017;37:3323-3329.
    >> Share

  79. STAMPFLI SF, Akhmedov A, Hausladen S, Varga Z, et al
    Tissue Factor Expression Does Not Predict Mortality in Breast Cancer Patients.
    Anticancer Res. 2017;37:3259-3264.
    >> Share

  80. BANYS-PALUCHOWSKI M, Witzel I, Riethdorf S, Rack B, et al
    Clinical Relevance of Serum HER2 and Circulating Tumor Cell Detection in Metastatic Breast Cancer Patients.
    Anticancer Res. 2017;37:3117-3128.
    >> Share

  81. GAVRESSEA T, Kalogeras KT, Koliou GA, Zagouri F, et al
    The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant Chemotherapy.
    Anticancer Res. 2017;37:2947-2957.
    >> Share

  82. CHRISTOPOULOS PF, Papageorgiou E, Petraki C, Koutsilieris M, et al
    The COOH-terminus of the IGF-1Ec Isoform Enhances the Proliferation and Migration of Human MCF-7 Breast Cancer Cells.
    Anticancer Res. 2017;37:2899-2912.
    >> Share

  83. KUBAN-JANKOWSKA A, Gorska-Ponikowska M, Wozniak M
    Lipoic Acid Decreases the Viability of Breast Cancer Cells and Activity of PTP1B and SHP2.
    Anticancer Res. 2017;37:2893-2898.
    >> Share

  84. NEUHAUSEN SL, Shani H, Boker LK, Steele L, et al
    Primary Peritoneal Serous Carcinoma in Men: A Rare and Non-BRCA-associated Entity.
    Anticancer Res. 2017;37:3069-3072.
    >> Share

    May 2017
  85. BYSTRICKY B, Cierna Z, Sieberova G, Janega P, et al
    Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.
    Anticancer Res. 2017;37:2727-2734.
    >> Share

  86. ESKELINEN M, Selander T, Ollonen P, Korhonen R, et al
    Moderate/severe Depression (MADRS) Can Affect the Quality of Life and Outcome Among Patients Admitted to Breast Cancer Diagnosis Unit.
    Anticancer Res. 2017;37:2641-2647.
    >> Share

  87. ANGELINI S, Botticelli A, Onesti CE, Giusti R, et al
    Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes.
    Anticancer Res. 2017;37:2633-2639.
    >> Share

  88. MIYATA M, Ohguri T, Yahara K, Yamaguchi S, et al
    Salvage Radiotherapy for Solitary Metachronous Bone Metastasis in Patients with Breast Cancer.
    Anticancer Res. 2017;37:2575-2579.
    >> Share

  89. KHAN GN, Kim EJ, Shin TS, Lee SH, et al
    Azacytidine-induced Chemosensitivity to Doxorubicin in Human Breast Cancer MCF7 Cells.
    Anticancer Res. 2017;37:2355-2364.
    >> Share

  90. STRATI TM, Kotoula V, Kostopoulos I, Manousou K, et al
    Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast Cancer.
    Anticancer Res. 2017;37:2323-2334.
    >> Share

  91. JIANG XP, Elliott RL
    Decreased Iron in Cancer Cells and Their Microenvironment Improves Cytolysis of Breast Cancer Cells by Natural Killer Cells.
    Anticancer Res. 2017;37:2297-2305.
    >> Share

  92. DA CRUZ PAULA A, Lopes C
    Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer.
    Anticancer Res. 2017;37:2173-2183.
    >> Share

    April 2017
  93. THANGARAJAH F, Enninga I, Malter W, Hamacher S, et al
    A Retrospective Analysis of Ki-67 Index and its Prognostic Significance in Over 800 Primary Breast Cancer Cases.
    Anticancer Res. 2017;37:1957-1964.
    >> Share

  94. INOUE Y, Yamashita N, Tokunaga E, Tanaka K, et al
    A Locally Advanced Breast Cancer that Achieved pCR with Pertuzumab, Trastuzumab and Docetaxel: Case Report.
    Anticancer Res. 2017;37:1917-1921.
    >> Share

  95. OKU Y, Nishiya N, Tsuda K, Shibazaki M, et al
    Dynamic Phenotypic Transition of Breast Cancer Cells In Vitro Revealed by Self-floating Cell Culture.
    Anticancer Res. 2017;37:1793-1797.
    >> Share

  96. BYSTRICKY B, Jurisova S, Karaba M, Minarik G, et al
    Relationship Between Circulating Tumor Cells and Tissue Plasminogen Activator in Patients with Early Breast Cancer.
    Anticancer Res. 2017;37:1787-1791.
    >> Share

  97. KIM KY, Park KI, Kim SH, Yu SN, et al
    Salinomycin Induces Reactive Oxygen Species and Apoptosis in Aggressive Breast Cancer Cells as Mediated with Regulation of Autophagy.
    Anticancer Res. 2017;37:1747-1758.
    >> Share

  98. DAS T, Nair RR, Green R, Padhee S, et al
    Actinomycin D Down-regulates SOX2 Expression and Induces Death in Breast Cancer Stem Cells.
    Anticancer Res. 2017;37:1655-1663.
    >> Share

  99. ACUNA UM, Curley RW Jr, Fatima N, Ahmed S, et al
    Differential Effect of Wortmannolone Derivatives on MDA-MB-231 Breast Cancer Cells.
    Anticancer Res. 2017;37:1617-1623.
    >> Share

  100. JELINEK M, Kabelova A, Sramek J, Seitz J, et al
    Differing Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells.
    Anticancer Res. 2017;37:1581-1590.
    >> Share

  101. CHIRICO A, Serpentini S, Merluzzi T, Mallia L, et al
    Self-efficacy for Coping Moderates the Effects of Distress on Quality of Life in Palliative Cancer Care.
    Anticancer Res. 2017;37:1609-1615.
    >> Share

  102. KAISER CG, Herold M, Krammer J, Baltzer P, et al
    Prognostic Value of "Prepectoral Edema" in MR-mammography.
    Anticancer Res. 2017;37:1989-1995.
    >> Share

  103. VOGL UM, Ohler L, Rasic M, Frischer JM, et al
    Evaluation of Prognostic Immune Signatures in Patients with Breast, Colorectal and Pancreatic Cancer Receiving Chemotherapy.
    Anticancer Res. 2017;37:1947-1955.
    >> Share

    March 2017
  104. KIM HA, Kim JH, Choi HS, Kim YG, et al
    Core Needle Biopsy Specimens Are More Appropriate than Surgical Specimens for Evaluating the Expression of Phosphoproteins as Biological Markers in Invasive Breast Cancer.
    Anticancer Res. 2017;37:1409-1412.
    >> Share

  105. DIERAS V, Pop S, Berger F, Dujaric ME, et al
    First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational Study.
    Anticancer Res. 2017;37:1403-1407.
    >> Share

  106. WENDT C, Lindblom A, Arver B, VON Wachenfeldt A, et al
    Parent of Origin and Prognosis in Familial Breast Cancer in Sweden.
    Anticancer Res. 2017;37:1257-1262.
    >> Share

  107. MACK N, Mazzio EA, Bauer D, Flores-Rozas H, et al
    Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
    Anticancer Res. 2017;37:1205-1212.
    >> Share

  108. WINDRICHOVA J, Fuchsova R, Kucera R, Topolcan O, et al
    MIC1/GDF15 as a Bone Metastatic Disease Biomarker.
    Anticancer Res. 2017;37:1501-1505.
    >> Share

  109. SEKIDO Y, Ohigashi S, Takahashi T, Hayashi N, et al
    Familial Gastrointestinal Stromal Tumor with Germline KIT Mutations Accompanying Hereditary Breast and Ovarian Cancer Syndrome.
    Anticancer Res. 2017;37:1425-1431.
    >> Share

  110. IIZUKA D, Sasatani M, Barcellos-Hoff MH, Kamiya K, et al
    Hydrogen Peroxide Enhances TGFbeta-mediated Epithelial-to-Mesenchymal Transition in Human Mammary Epithelial MCF-10A Cells.
    Anticancer Res. 2017;37:987-995.
    >> Share

    February 2017
  111. ILENKO A, Sergent F, Mercuzot A, Zitoun M, et al
    Could Patients Older than 75 Years Benefit from a Systematic Breast Cancer Screening Program?
    Anticancer Res. 2017;37:903-907.
    >> Share

  112. LAWLER G, Leech M
    Dose Sparing Potential of Deep Inspiration Breath-hold Technique for Left Breast Cancer Radiotherapy Organs-at-risk.
    Anticancer Res. 2017;37:883-890.
    >> Share

  113. ESKELINEN M, Korhonen R, Selander T, Ollonen P, et al
    Beck Depression Inventory as a Predictor of Long-term Outcome Among Patients Admitted to the Breast Cancer Diagnosis Unit: A 25-year Cohort Study in Finland.
    Anticancer Res. 2017;37:819-824.
    >> Share

  114. WU HC, Southey MC, Hibshoosh H, Santella RM, et al
    DNA Methylation in Breast Tumor from High-risk Women in the Breast Cancer Family Registry.
    Anticancer Res. 2017;37:659-664.
    >> Share

  115. ONISHI H, Suyama K, Yamasaki A, Oyama Y, et al
    CD24 Modulates Chemosensitivity of MCF-7 Breast Cancer Cells.
    Anticancer Res. 2017;37:561-565.
    >> Share

    January 2017

  116. Radiation Therapy Techniques and Treatment Planning for Breast Cancer.
    Anticancer Res. 2017;37:369-370.
    >> Share

  117. The Pathobiology of Breast Cancer.
    Anticancer Res. 2017;37:365.
    >> Share

  118. YANG X, DU G, Yu Z, Si Y, et al
    A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.
    Anticancer Res. 2017;37:67-73.
    >> Share

  119. YANO S, Takehara K, Kishimoto H, Tazawa H, et al
    Comparison of Tumor Recurrence After Resection of Highly- and Poorly-Metastatic Triple-negative Breast Cancer in Orthotopic Nude-Mouse Models.
    Anticancer Res. 2017;37:57-60.
    >> Share

  120. DAMASKOS C, Valsami S, Kontos M, Spartalis E, et al
    Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer.
    Anticancer Res. 2017;37:35-46.
    >> Share

  121. STRIEN L, Joensuu K, Heikkila P, Leidenius MH, et al
    Different Expression Patterns of CXCR4, CCR7, Maspin and FOXP3 in Luminal Breast Cancers and Their Sentinel Node Metastases.
    Anticancer Res. 2017;37:175-182.
    >> Share

  122. GIPPONI M, Baldelli I, Atzori G, Fregatti P, et al
    Tumescent Anesthesia in Skin- and Nipple-sparing Mastectomy: Results of a Prospective Clinical Study.
    Anticancer Res. 2017;37:349-352.
    >> Share

  123. SCHRODER L, Koch J, Mahner S, Kost BP, et al
    The Effects of Petroselinum Crispum on Estrogen Receptor-positive Benign and Malignant Mammary Cells (MCF12A/MCF7).
    Anticancer Res. 2017;37:95-102.
    >> Share

    December 2016
  124. RAY A, Khong B, Khong HT
    A Case Report of Pneumocystis Jiroveci Pneumonia in a Patient with Metastatic Breast Cancer.
    Anticancer Res. 2016;36:6673-6676.
    >> Share

  125. LUKESOVA L, Vrana D, Svach I, Zlamalova N, et al
    Prognostic Influence of Internal Mammary Node Drainage in Patients with Early-stage Breast Cancer.
    Anticancer Res. 2016;36:6641-6646.
    >> Share

  126. SAKAGUCHI K, Nakatsukasa K, Taguchi T
    Phase I Study of Triweekly Nab-Paclitaxel Combined with S-1 in Patients with HER2-negative Metastatic Breast Cancer.
    Anticancer Res. 2016;36:6515-6519.
    >> Share

  127. TANAKA S, Iwamoto M, Kimura K, Takahashi Y, et al
    A Phase II Study of Adjuvant Chemotherapy of Tegafur-Uracil for Patients with Breast Cancer with HER2-negative Pathologic Residual Invasive Disease After Neoadjuvant Chemotherapy.
    Anticancer Res. 2016;36:6505-6509.
    >> Share

  128. TIAINEN L, Tanner M, Lahdenpera O, Vihinen P, et al
    Bevacizumab Combined with Docetaxel or Paclitaxel as First-line Treatment of HER2-negative Metastatic Breast Cancer.
    Anticancer Res. 2016;36:6431-6438.
    >> Share

  129. RAMDANI LH, Talhi O, Taibi N, Delort L, et al
    Effects of Spiro-bisheterocycles on Proliferation and Apoptosis in Human Breast Cancer Cell Lines.
    Anticancer Res. 2016;36:6399-6408.
    >> Share

  130. LEE J, Jung JH, Chae YS, Park HY, et al
    Long Noncoding RNA snaR Regulates Proliferation, Migration and Invasion of Triple-negative Breast Cancer Cells.
    Anticancer Res. 2016;36:6289-6295.
    >> Share

  131. YANO S, Takehara K, Kishimoto H, Tazawa H, et al
    In Vivo Selection of Intermediately- and Highly-Malignant Variants of Triple-negative Breast Cancer in Orthotopic Nude Mouse Models.
    Anticancer Res. 2016;36:6273-6277.
    >> Share

    November 2016
  132. SHINDEN Y, Kijima Y, Hirata M, Arima H, et al
    Clinical Significance of the Histoculture Drug Response Assay in Breast Cancer.
    Anticancer Res. 2016;36:6173-6178.
    >> Share

  133. LEE SJ, Park BN, Roh JH, An YS, et al
    Enhancing the Therapeutic Efficacy of 2-Deoxyglucose in Breast Cancer Cells Using Cell-cycle Synchronization.
    Anticancer Res. 2016;36:5975-5980.
    >> Share

  134. PIRES BR, DE Amorim IS, Souza LD, Rodrigues JA, et al
    Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
    Anticancer Res. 2016;36:5681-5691.
    >> Share

    Immune Blockade Inhibition in Breast Cancer.
    Anticancer Res. 2016;36:5607-5622.
    >> Share

    October 2016
  136. WALDREP AR, Avery EJ, Rose FF Jr, Midathada MV, et al
    Breast Cancer Subtype Influences the Accuracy of Predicting Pathologic Response by Imaging and Clinical Breast Exam After Neoadjuvant Chemotherapy.
    Anticancer Res. 2016;36:5389-5395.
    >> Share

  137. QIN W, Holick MF, Sorensen W, Walker CR, et al
    Vitamin D3 Treatment Influences PGE2 and TGFbeta in Normal and Increased Breast Cancer Risk Women.
    Anticancer Res. 2016;36:5347-5353.
    >> Share

  138. VILSMAIER T, Rack B, Konig A, Friese K, et al
    Influence of Circulating Tumour Cells on Production of IL-1alpha, IL-1beta and IL-12 in Sera of Patients with Primary Diagnosis of Breast Cancer Before Treatment.
    Anticancer Res. 2016;36:5227-5236.
    >> Share

  139. TAKEDA S, Okazaki H, Kudo T, Kakizoe K, et al
    Bongkrekic Acid as a Warburg Effect Modulator in Long-term Estradiol-deprived MCF-7 Breast Cancer Cells.
    Anticancer Res. 2016;36:5171-5182.
    >> Share

  140. GANGAPURAM M, Jean R, Mazzio E, Badisa R, et al
    Substituted Tetrahydroisoquinolines as Microtubule-destabilizing Agents in Triple Negative Human Breast Cancer Cells.
    Anticancer Res. 2016;36:5043-5052.
    >> Share

  141. SHAVERDIAN N, Wang J, Levin-Epstein R, Schaue D, et al
    Pro-inflammatory State Portends Poor Outcomes with Stereotactic Radiosurgery for Brain Metastases.
    Anticancer Res. 2016;36:5333-5337.
    >> Share

  142. STAHL JM, Hong JC, Lester-Coll NH, Kann BH, et al
    Chest Wall Deformity in the Radiation Oncology Clinic.
    Anticancer Res. 2016;36:5295-5300.
    >> Share

  143. FUJII T, Yajima R, Kurozumi S, Higuchi T, et al
    Clinical Significance of 18F-FDG-PET in Invasive Lobular Carcinoma.
    Anticancer Res. 2016;36:5481-5485.
    >> Share

    September 2016
  144. RIOS N, Adaskina N, Fromke C, Papendorf F, et al
    The Benefit of Baseline Staging-Risk Assessment of Distant Breast Cancer Metastases by Tumor Stage.
    Anticancer Res. 2016;36:4909-14.
    >> Share

  145. KIM YJ, Kim K, Lee R, Kim J, et al
    Two-year Follow-up of Volumetric-modulated Arc Therapy for Treating Internal Mammary Nodes in Locally Advanced Breast Cancer.
    Anticancer Res. 2016;36:4847-51.
    >> Share

  146. HEPP P, Andergassen U, Jager B, Trapp E, et al
    Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.
    Anticancer Res. 2016;36:4771-6.
    >> Share

  147. FURRER D, Jacob S, Caron C, Sanschagrin F, et al
    Tissue Microarray Is a Reliable Tool for the Evaluation of HER2 Amplification in Breast Cancer.
    Anticancer Res. 2016;36:4661-6.
    >> Share

  148. WAZIR U, El Hage Chehade H, Headon H, Oteifa M, et al
    Oncological Safety of Lipofilling in Patients with Breast Cancer: A Meta-analysis and Update on Clinical Practice.
    Anticancer Res. 2016;36:4521-8.
    >> Share

  149. KAPPIL M, Terry MB, Delgado-Cruzata L, Liao Y, et al
    Mismatch Repair Polymorphisms as Markers of Breast Cancer Prevalence in the Breast Cancer Family Registry.
    Anticancer Res. 2016;36:4437-41.
    >> Share

  150. DO SI, Yoon G, Kim HS, Kim K, et al
    Increased Brahma-related Gene 1 Expression Predicts Distant Metastasis and Shorter Survival in Patients with Invasive Ductal Carcinoma of the Breast.
    Anticancer Res. 2016;36:4873-82.
    >> Share

    August 2016

  151. Handbook of HER2-Targeted Agents in Breast Cancer.
    Anticancer Res. 2016;36:4377.
    >> Share

  152. KARLIKOVA M, Topolcan O, Narsanska A, Kucera R, et al
    Circulating Growth and Angiogenic Factors and Lymph Node Status in Early-stage Breast Cancer - A Pilot Study.
    Anticancer Res. 2016;36:4209-14.
    >> Share

  153. PIMENTEL C, Becquet M, Lavoue V, Henno S, et al
    Ovarian Metastases from Breast Cancer: A Series of 28 Cases.
    Anticancer Res. 2016;36:4195-200.
    >> Share

  154. KAPPIL MA, Liao Y, Terry MB, Santella RM, et al
    DNA Repair Gene Expression Levels as Indicators of Breast Cancer in the Breast Cancer Family Registry.
    Anticancer Res. 2016;36:4039-44.
    >> Share

  155. CHIANG KC, Hsu SY, Lin SJ, Yeh CN, et al
    PTEN Insufficiency Increases Breast Cancer Cell Metastasis In Vitro and In Vivo in a Xenograft Zebrafish Model.
    Anticancer Res. 2016;36:3997-4005.
    >> Share

  156. FULAWKA L, Halon A
    Proliferation Index Evaluation in Breast Cancer Using ImageJ and ImmunoRatio Applications.
    Anticancer Res. 2016;36:3965-72.
    >> Share

  157. HOWARD CB, McDowell R, Feleke K, Deer E, et al
    Chemotherapeutic Vulnerability of Triple-negative Breast Cancer Cell-derived Tumors to Pretreatment with Vernonia amygdalina Aqueous Extracts.
    Anticancer Res. 2016;36:3933-43.
    >> Share

  158. BENDRAT K, Fritz P, Muller S, Brockmoller S, et al
    Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone Receptor.
    Anticancer Res. 2016;36:3855-63.
    >> Share

  159. YANO S, Takehara K, Miwa S, Kishimoto H, et al
    In Vivo Isolation of a Highly-aggressive Variant of Triple-negative Human Breast Cancer MDA-MB-231 Using Serial Orthotopic Transplantation.
    Anticancer Res. 2016;36:3817-20.
    >> Share

  160. Breast Disease. Management and Therapies.
    Anticancer Res. 2016;36:4376.
    >> Share

  161. LUCZYNSKA E, Heinze S, Adamczyk A, Rys J, et al
    Comparison of the Mammography, Contrast-Enhanced Spectral Mammography and Ultrasonography in a Group of 116 patients.
    Anticancer Res. 2016;36:4359-66.
    >> Share

  162. FUJII T, Yajima R, Kuwano H
    Implications of Long-term Indwelling of Tissue Expander in Breast Reconstruction: Risk of Expander Rupturing.
    Anticancer Res. 2016;36:4337-40.
    >> Share

    July 2016
  163. NAM SO, Yotsumoto F, Miyata K, Fukagawa S, et al
    Anti-tumor Effect of Intravenous Administration of CRM197 for Triple-negative Breast Cancer Therapy.
    Anticancer Res. 2016;36:3651-7.
    >> Share

  164. SHIMAMURA Y, Tamatani D, Kuniyasu S, Mizuki Y, et al
    5-Aminolevulinic Acid Enhances Ultrasound-mediated Antitumor Activity via Mitochondrial Oxidative Damage in Breast Cancer.
    Anticancer Res. 2016;36:3607-12.
    >> Share

  165. CRISCITIELLO C, Bagnardi V, Viale G, Disalvatore D, et al
    HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence.
    Anticancer Res. 2016;36:3537-40.
    >> Share

  166. SU CH, Lane HY, Hsiao CL, Liu LC, et al
    Matrix Metalloproteinase-1 Genetic Polymorphism in Breast Cancer in Taiwanese.
    Anticancer Res. 2016;36:3341-3345.
    >> Share

  167. SAMARA P, Skopeliti M, Tsiatas ML, Georgaki S, et al
    A Cytokine Cocktail Augments the Efficacy of Adoptive NK-92 Cell Therapy Against Mouse Xenografts of Human Cancer.
    Anticancer Res. 2016;36:3373-82.
    >> Share

    June 2016

  168. Novel Biomarkers in the Continuum of Breast Cancer.
    Anticancer Res. 2016;36:3224.
    >> Share

  169. ANDERGASSEN U, Vogl A, Mumm JN, Kolbl AC, et al
    Immunocytochemical Characterization of Disseminated Tumour Cells from Bone Marrow of Breast Cancer Patients.
    Anticancer Res. 2016;36:3217-22.
    >> Share

  170. KOLBL AC, Brauer D, Hutter S, Rack B, et al
    New Marker Genes for Real-Time PCR-based Detection of Circulating Tumour Cells from Blood of Breast Cancer Patients.
    Anticancer Res. 2016;36:3211-6.
    >> Share

  171. KOLBEN T, Hary T, Holdt LM, Schwarz TM, et al
    Thyroid Hormones and Vitamin D in Patients with Breast Cancer with Mutations in BRCA1 or BRCA2 Genes.
    Anticancer Res. 2016;36:3185-90.
    >> Share

  172. FREIER CP, Kuhn C, Endres S, Mayr D, et al
    FOXP3+ Cells Recruited by CCL22 into Breast Cancer Correlates with Less Tumor Nodal Infiltration.
    Anticancer Res. 2016;36:3139-45.
    >> Share

  173. KONIG A, Vilsmaier T, Rack B, Friese K, et al
    Determination of Interleukin-4, -5, -6, -8 and -13 in Serum of Patients with Breast Cancer Before Treatment and its Correlation to Circulating Tumor Cells.
    Anticancer Res. 2016;36:3123-30.
    >> Share

  174. FUJII T, Yajima R, Tsuboi M, Higuchi T, et al
    Clinicopathological Features of Cases with Primary Breast Cancer not Identified by 18F-FDG-PET.
    Anticancer Res. 2016;36:3019-22.
    >> Share

  175. SHIMA H, Kutomi G, Satomi F, Maeda H, et al
    SOX2 and ALDH1 as Predictors of Operable Breast Cancer.
    Anticancer Res. 2016;36:2945-53.
    >> Share

  176. BRAUTIGAM K, Mitzlaff K, Uebel L, Koster F, et al
    Subtypes of Triple-negative Breast Cancer Cell Lines React Differently to Eribulin Mesylate.
    Anticancer Res. 2016;36:2759-66.
    >> Share

  177. SCHELZ Z, Ocsovszki I, Bozsity N, Hohmann J, et al
    Antiproliferative Effects of Various Furanoacridones Isolated from Ruta graveolens on Human Breast Cancer Cell Lines.
    Anticancer Res. 2016;36:2751-8.
    >> Share

  178. KASSAYOVA M, Bobrov N, Strojny L, Orendas P, et al
    Anticancer and Immunomodulatory Effects of Lactobacillus plantarum LS/07, Inulin and Melatonin in NMU-induced Rat Model of Breast Cancer.
    Anticancer Res. 2016;36:2719-28.
    >> Share

  179. KIM JY, Heo SH, Song IH, Park IA, et al
    Activation of the PERK-eIF2alpha Pathway Is Associated with Tumor-infiltrating Lymphocytes in HER2-Positive Breast Cancer.
    Anticancer Res. 2016;36:2705-11.
    >> Share

  180. MIN DJ, He S, Green JE
    Birinapant (TL32711) Improves Responses to GEM/AZD7762 Combination Therapy in Triple-negative Breast Cancer Cell Lines.
    Anticancer Res. 2016;36:2649-57.
    >> Share

    April 2016
  181. WINDRICHOVA J, Fuchsova R, Kucera R, Topolcan O, et al
    Testing of a Novel Cancer Metastatic Multiplex Panel for the Detection of Bone-metastatic Disease - a Pilot Study.
    Anticancer Res. 2016;36:1973-8.
    >> Share

  182. RAPOSO TP, Beirao BC, Pires I, Prada J, et al
    Immunohistochemical Expression of CCR2, CSF1R and MMP9 in Canine Inflammatory Mammary Carcinomas.
    Anticancer Res. 2016;36:1805-13.
    >> Share

  183. MOSS T, Chirico A, Mallia L, Lucidi F, et al
    Psychosocial Outcomes of Quadrantectomy Versus Mastectomy in a Southern Italian Sample: Development and Needs of the Italian Derriford Appearance Scale 24.
    Anticancer Res. 2016;36:1519-26.
    >> Share

    March 2016
  184. CUI YX, Evans BA, Jiang WG
    New Roles of Osteocytes in Proliferation, Migration and Invasion of Breast and Prostate Cancer Cells.
    Anticancer Res. 2016;36:1193-201.
    >> Share

    February 2016
  185. AMABILE MI, Monti M, Merola R, Frusone F, et al
    Nipple-sparing Mastectomy in Patients with Preoperative Diagnosis of Non-invasive Breast Carcinoma. A Single-center Experience.
    Anticancer Res. 2016;36:779-83.
    >> Share

  186. KUCERA R, Topolcan O, Fiala O, Kinkorova J, et al
    The Role of TPS and TPA in the Diagnostics of Distant Metastases.
    Anticancer Res. 2016;36:773-7.
    >> Share

    January 2016
  187. GITT A, Bose-Ribeiro H, Nieder C, Kup PG, et al
    Treatment Results of MammoSite Catheter in Combination with Whole-breast Irradiation.
    Anticancer Res. 2016;36:355-60.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016